Ebenezer’s background is in economics, strategy, and planning. His international experience crosses various industries: investment banking, energy, chemicals, biotechnology, pharmaceuticals, and medical devices.
He
began his career at Citigroup working in foreign exchange before moving to Royal Dutch Shell. Ebenezer has spent the last 6 years providing economic solutions to pharmaceutical companies, consultancies, and
the NHS.
Ebenezer’s experience within the health sector spans a variety of disciplines including health economics, market access, and strategy portfolio . Ebenezer was a technical lead at OptumInsight
where he led economic model development for Pfizer, Gilead, and Lundbeck. He also successfully delivered a detailed strategy recommendation on the restructuring of a local health economy for NHS England. Ebenezer
has also worked for Deloitte, Parexel, and IMSCG.
Currently, Ebenezer splits his time between health market access, dossier submissions, and technology commercialisation.
Ebenezer has an MPhil
from the University of Cambridge and MIT in Economics (Technology Policy) and a BSc Hons degree in Computer Science and Artificial Intelligence from the University of Edinburgh. He expects to graduate in 2018
from the University of Oxford with a MSc in Biomedical Engineering.